JP2025128174A5 - - Google Patents

Info

Publication number
JP2025128174A5
JP2025128174A5 JP2025087103A JP2025087103A JP2025128174A5 JP 2025128174 A5 JP2025128174 A5 JP 2025128174A5 JP 2025087103 A JP2025087103 A JP 2025087103A JP 2025087103 A JP2025087103 A JP 2025087103A JP 2025128174 A5 JP2025128174 A5 JP 2025128174A5
Authority
JP
Japan
Prior art keywords
polysaccharide
immunogenic composition
carrier protein
kda
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2025087103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025128174A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/049306 external-priority patent/WO2019050814A1/en
Application filed filed Critical
Publication of JP2025128174A publication Critical patent/JP2025128174A/ja
Publication of JP2025128174A5 publication Critical patent/JP2025128174A5/ja
Withdrawn legal-status Critical Current

Links

JP2025087103A 2017-09-07 2025-05-26 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用 Withdrawn JP2025128174A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762555455P 2017-09-07 2017-09-07
US62/555,455 2017-09-07
PCT/US2018/049306 WO2019050814A1 (en) 2017-09-07 2018-09-04 ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
JP2020513530A JP2020533437A (ja) 2017-09-07 2018-09-04 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
JP2023096312A JP2023113922A (ja) 2017-09-07 2023-06-12 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023096312A Division JP2023113922A (ja) 2017-09-07 2023-06-12 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用

Publications (2)

Publication Number Publication Date
JP2025128174A JP2025128174A (ja) 2025-09-02
JP2025128174A5 true JP2025128174A5 (cg-RX-API-DMAC7.html) 2025-10-10

Family

ID=65635315

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020513530A Pending JP2020533437A (ja) 2017-09-07 2018-09-04 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
JP2023096312A Pending JP2023113922A (ja) 2017-09-07 2023-06-12 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用
JP2025087103A Withdrawn JP2025128174A (ja) 2017-09-07 2025-05-26 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020513530A Pending JP2020533437A (ja) 2017-09-07 2018-09-04 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
JP2023096312A Pending JP2023113922A (ja) 2017-09-07 2023-06-12 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用

Country Status (10)

Country Link
US (6) US11491216B2 (cg-RX-API-DMAC7.html)
EP (1) EP3678655A4 (cg-RX-API-DMAC7.html)
JP (3) JP2020533437A (cg-RX-API-DMAC7.html)
KR (2) KR102783492B1 (cg-RX-API-DMAC7.html)
CN (2) CN117736348A (cg-RX-API-DMAC7.html)
AU (2) AU2018328036B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020004396A8 (cg-RX-API-DMAC7.html)
CA (1) CA3074706A1 (cg-RX-API-DMAC7.html)
MX (2) MX2020002559A (cg-RX-API-DMAC7.html)
WO (1) WO2019050814A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
BR112016015835B1 (pt) * 2014-01-21 2023-12-26 Pfizer Inc Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
IL267709B2 (en) 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CN110225757A (zh) * 2017-01-31 2019-09-10 默沙东公司 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
WO2018144439A1 (en) 2017-01-31 2018-08-09 Merck Sharp & Dohme Corp. Methods for making polysaccharide-protein conjugates
WO2019050818A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. METHODS OF FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
US11400162B2 (en) 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
JP7680185B2 (ja) * 2017-02-24 2025-05-20 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CA3074706A1 (en) * 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
HUE068482T2 (hu) * 2017-09-07 2025-01-28 Merck Sharp & Dohme Llc Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
EP3691677A4 (en) * 2017-10-04 2021-07-07 Pogona, Llc COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE
EP3720483B1 (en) 2017-12-06 2025-11-19 Merck Sharp & Dohme LLC Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2019212842A1 (en) 2018-04-30 2019-11-07 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
JP7397000B2 (ja) 2018-04-30 2023-12-12 メルク・シャープ・アンド・ドーム・エルエルシー 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
WO2019212846A1 (en) 2018-04-30 2019-11-07 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
MX2021003358A (es) 2018-09-23 2021-05-27 Biological E Ltd Polisacaridos capsulares purificados de streptococcus pneumoniae.
EP3897705A2 (en) 2018-12-19 2021-10-27 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CN115362177A (zh) * 2020-02-21 2022-11-18 辉瑞公司 糖类的纯化
US20240123047A1 (en) * 2021-02-04 2024-04-18 Merck Sharp & Dohme Llc Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccines
EP4622665A2 (en) 2022-11-22 2025-10-01 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN120513083A (zh) 2022-12-01 2025-08-19 辉瑞大药厂 肺炎链球菌缀合物疫苗制剂
TW202527906A (zh) 2023-09-14 2025-07-16 美商輝瑞股份有限公司 包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
WO2025219908A2 (en) 2024-04-19 2025-10-23 Pfizer Inc. Media and fermentation methods for polysaccharide production in bacterial cell culture

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US7955605B2 (en) * 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
IL308456A (en) * 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
AU2006336520B2 (en) * 2005-12-28 2011-09-15 The Uab Research Foundation Pneumococcal serotypes
GB0703369D0 (en) * 2007-02-21 2007-03-28 Health Prot Agency Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines
CN102186495B (zh) * 2008-07-31 2014-11-26 美国政府健康及人类服务部,疾病控制和预防中心 用于增强调理吞噬作用的肺炎球菌p4肽在对病原体应答中的应用
TW201136603A (en) 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
EP3626263A1 (en) 2010-06-04 2020-03-25 Wyeth LLC Vaccine formulations
US20130273098A1 (en) * 2010-12-10 2013-10-17 Jeffrey T. Blue Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
WO2013131983A1 (en) * 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
PT2885007T (pt) 2012-08-16 2018-12-10 Pfizer Processos e composições de glicoconjugação
CN103623401A (zh) * 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
US11160855B2 (en) * 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IL312327B2 (en) * 2014-01-21 2026-02-01 Pfizer Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
BR112016015835B1 (pt) * 2014-01-21 2023-12-26 Pfizer Inc Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
ES2930318T3 (es) * 2014-02-14 2022-12-09 Pfizer Conjugados glucoproteicos inmunogénicos
AR104469A1 (es) * 2014-08-08 2017-07-26 Glycovaxyn Ag Células huésped modificadas para su uso en producción de bioconjugados
US10729780B2 (en) * 2015-06-08 2020-08-04 Serum Institute Of India Private Ltd. Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof
KR20250058066A (ko) * 2015-07-21 2025-04-29 화이자 인코포레이티드 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
JP6024841B1 (ja) * 2016-01-27 2016-11-16 株式会社リコー 照明装置、パターン照射装置およびシステム
US11058757B2 (en) 2016-03-31 2021-07-13 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
CN109311924B (zh) * 2016-04-14 2020-04-17 马克斯·普朗克科学促进学会 针对肺炎链球菌3型的疫苗的改善的制备
GB201610599D0 (en) * 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
DE112016006945T5 (de) * 2016-06-30 2019-03-28 Ford Global Technologies, Llc Systeme, verfahren und vorrichtungen für einen rahmenfesten pedaltrittfrequenzsensor
CN110225757A (zh) 2017-01-31 2019-09-10 默沙东公司 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
WO2018144439A1 (en) 2017-01-31 2018-08-09 Merck Sharp & Dohme Corp. Methods for making polysaccharide-protein conjugates
JP7680185B2 (ja) * 2017-02-24 2025-05-20 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
WO2019050818A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. METHODS OF FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
CN110392690B (zh) 2017-02-24 2024-01-30 默沙东有限责任公司 肺炎球菌缀合物疫苗制剂
US11219680B2 (en) * 2017-02-24 2022-01-11 Merck Sharp & Dohme Corp. Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
US20200061542A1 (en) 2017-02-24 2020-02-27 Merck Sharp & Dohme Corp. Methods for improving filterability of polysaccharide-protein conjugate reactions
US11739356B2 (en) * 2017-05-05 2023-08-29 Serum Institute Of India Private Limited Method for removal of impurities from bacterial capsular polysaccharide based preparations
GB201711637D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
GB201711635D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
WO2019036313A1 (en) 2017-08-16 2019-02-21 Merck Sharp & Dohme Corp. CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
HUE068482T2 (hu) 2017-09-07 2025-01-28 Merck Sharp & Dohme Llc Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
US11395849B2 (en) * 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CA3074706A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN111065387B (zh) * 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
US11524076B2 (en) * 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
WO2019083865A1 (en) 2017-10-25 2019-05-02 Merck Sharp & Dohme Corp. VACCINES WITH ADJUVANT
EP3720483B1 (en) * 2017-12-06 2025-11-19 Merck Sharp & Dohme LLC Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2019212842A1 (en) * 2018-04-30 2019-11-07 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
EP3897705A2 (en) * 2018-12-19 2021-10-27 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
KR20210010412A (ko) * 2019-07-18 2021-01-27 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
US12053515B2 (en) * 2020-08-10 2024-08-06 Inventprise, Inc. Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F

Similar Documents

Publication Publication Date Title
JP2020533439A5 (cg-RX-API-DMAC7.html)
JP2020533437A5 (cg-RX-API-DMAC7.html)
JP2024056835A5 (cg-RX-API-DMAC7.html)
JP2020533438A5 (cg-RX-API-DMAC7.html)
JP2020533442A5 (cg-RX-API-DMAC7.html)
IL276230B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
IL276229B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
Thompson et al. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults
US10688170B2 (en) Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
JP2024009978A5 (cg-RX-API-DMAC7.html)
TW202617178A (zh) 多價肺炎球菌多醣-蛋白質共軛物組成物及使用其之方法
ME01334B (me) Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom
JP2022542316A5 (cg-RX-API-DMAC7.html)
RU2016136630A (ru) Способы гликоконъюгирования и композиции
JP2021505589A5 (cg-RX-API-DMAC7.html)
JP2021512870A5 (cg-RX-API-DMAC7.html)
JP2010132925A5 (cg-RX-API-DMAC7.html)
US12251438B2 (en) Immunogenic compositions of polysaccharide-protein pegylated compounds
JP2019526620A5 (cg-RX-API-DMAC7.html)
JP2022535064A5 (cg-RX-API-DMAC7.html)
JP2022513562A5 (cg-RX-API-DMAC7.html)
JP2025029014A5 (cg-RX-API-DMAC7.html)
JP2024103612A5 (cg-RX-API-DMAC7.html)
RU2020112309A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2020112312A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель